BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28199992)

  • 1. Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers.
    Karras JR; Schrock MS; Batar B; Huebner K
    Cytogenet Genome Res; 2016; 150(3-4):208-216. PubMed ID: 28199992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome.
    Saldivar JC; Park D
    Genes Chromosomes Cancer; 2019 May; 58(5):317-323. PubMed ID: 30242938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.
    Hosseini SA; Horton S; Saldivar JC; Miuma S; Stampfer MR; Heerema NA; Huebner K
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1017-29. PubMed ID: 23929738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of genome instability and preneoplastic processes through loss of Fhit expression.
    Saldivar JC; Miuma S; Bene J; Hosseini SA; Shibata H; Sun J; Wheeler LJ; Mathews CK; Huebner K
    PLoS Genet; 2012; 8(11):e1003077. PubMed ID: 23209436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
    Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
    Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common fragile genes and digestive tract cancers.
    Kuroki T; Tajima Y; Furui J; Kanematsu T
    Surg Today; 2006; 36(1):1-5. PubMed ID: 16378185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.
    Thavathiru E; Ludes-Meyers JH; MacLeod MC; Aldaz CM
    Mol Carcinog; 2005 Nov; 44(3):174-82. PubMed ID: 16187332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large common fragile site genes and cancer.
    Smith DI; McAvoy S; Zhu Y; Perez DS
    Semin Cancer Biol; 2007 Feb; 17(1):31-41. PubMed ID: 17140807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FHIT gene product: tumor suppressor and genome "caretaker".
    Waters CE; Saldivar JC; Hosseini SA; Huebner K
    Cell Mol Life Sci; 2014 Dec; 71(23):4577-87. PubMed ID: 25283145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of FHIT and WWOX fragile genes in cancer.
    Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
    Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
    Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
    Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordant loss of fragile gene expression early in breast cancer development.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
    Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of
    Simón-Carrasco L; Pietrini E; López-Contreras AJ
    Cell Cycle; 2024 Jan; 23(1):92-113. PubMed ID: 38234243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular parameters of genome instability: roles of fragile genes at common fragile sites.
    Pichiorri F; Ishii H; Okumura H; Trapasso F; Wang Y; Huebner K
    J Cell Biochem; 2008 Aug; 104(5):1525-33. PubMed ID: 18393361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.